Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: A 19-week, phase ii, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease
Titel:
Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: A 19-week, phase ii, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease
Auteur:
Besarab, Anatole Salifu, Moro O. Lunde, N. Martin Bansal, Vinod Fishbane, Steven Dougherty, Frank C. Beyer, Ulrich